Actively Recruiting

Age: 18Years +
All Genders
ID06794203

Hyperthyroidism in the Immediate Post-kidney Transplantation Period: a Potential Predictive of Worse Outcome of Renal Graft

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-27

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to study kidney transplant patients to understand if changes in thyroid function shortly after the transplant relate to the transplant's success and patient outcomes. The study focuses on how thyroid hormone changes might affect kidney function, medical complications, and patient survival within three months post-transplant. It also seeks to identify risk factors for thyroid disorders during this early post-transplant period. Participants are kidney transplant patients from a specific hospital center. Researchers will monitor thyroid function at the time of transplant and again three months later. They will also assess kidney function, medical complications occurring from surgery until discharge, and survival at three months. The study will include about 100 patients who meet the criteria. During the study, participants' thyroid and kidney functions will be tested through clinical and laboratory data collection. Medical complications and survival will be tracked from surgery to three months after transplantation. Participants must have data available within 30 days post-transplant and provide informed consent. The total follow-up period covers up to three months after the kidney transplant to evaluate outcomes and safety.

CONDITIONS

Brief Title

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects transplanted at our Center
  • Subjects whose 3-month follow-up is available
  • Age 65;18 years
  • Availability of clinical and laboratory data regarding thyroid function trends in the immediate post-transplant period (within 30 days after transplantation)
  • Subjects giving informed consent to participate
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within 30 days after transplantation

Participants undergo thyroid function assessments and other clinical evaluations immediately following kidney transplantation.

Baseline visit around the time of surgery and assessments within the first month post-transplant

Long-term Monitoring

Duration - Up to 3 months after transplantation

Participants are monitored for renal function, medical complications, and survival outcomes up to three months after transplantation.

Follow-up visits at patient discharge and at 3 months post-transplant

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, BO, Italy, 40138

Actively Recruiting

Loading map...

Research Team

G

Gaetano La Manna, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Retrospective and Prospective Observational Study of Hyper...

Hyperthyroidism

Actively Recruiting

1 location

A Contrast Medium Sparing Strategy Using Automated Carbon Di...

Peripheral Vascular Diseases

Actively Recruiting

11 locations

A Mixed Cohort, Multicentre Exploratory Study of Non-invasiv...

Kidney Transplant

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here